Skip to main content
. 2021 Jan 5;96(1):e67–e80. doi: 10.1212/WNL.0000000000010996

Table 2.

Hazard Ratios (HRs) for Individuals Using Angiotensin II–Stimulating (Ang+) or Both Ang+ and Angiotensin II–Inhibiting (Ang−) Antihypertensives Compared With Those Using Ang− Antihypertensives Only

graphic file with name NEUROLOGY2020066860TT2.jpg